Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.02 0.81 1.19 1.29
P/FCF ratio
14.72 12.07 15.76 16.25
P/Operating CF
37.57 90.25 51.08 41.02
P/B ratio
1.19 0.95 1.40 1.53
EV/Sales
1.54 1.35 1.74 1.84
EV/EBITDA
80.81 68.22 65.97 17.75
EV/FCF
22.18 20.13 22.99 23.14
Current Ratio
1.78 1.76 1.78 1.49
Net Debt/EBITDA
14.80 17.14 15.46 (6.65)
Debt/Equity
0.66 0.68 0.71 0.69
Earnings Yield
(8.48%) (10.33%) (6.81%) (0.96%)
Free Cash Flow Yield
6.79% 8.29% 6.35% 6.15%
Free Cash Flow per Share
0.21 0.04 0.17 0.25
Book value per Share
8.33 8.27 8.18 8.17
Free Cash Flow
140.60 25.20 117.20 171.70
EV/EBIT
0.00 0.00 0.00 45.63
Other line items

Show all line items

Columns are period end dates